Skip to main content
. 2014 Feb 18;123(15):2378–2388. doi: 10.1182/blood-2013-10-534271

Figure 4.

Figure 4

Distribution and characteristics of the CNAs identified in the discovery and screening panels. (A) Distribution of the CNAs identified in FR-CLL belonging to the discovery and screening panels. (B) Identification of cases with an outlier number of CNAs. (C) Type of CNAs.